无创双水平气道正压通气(BiPAP)治疗老年慢阻肺并发呼吸衰竭患者的临床效果及并发症影响  

The clinical effect and complications of noninvasive bi-level positive airway pressure (BiPAP) in elderly patients with chronic obstructive pulmonary disease (COPD) complicated with respiratory failure

作　　者：索爽 李鹏飞[1] Su Shuang;Li Pengfei(Department of Respiratory and Critical Care Medicine,Mentougou District Hospital of Beijing 102300)

机构地区：[1]北京市门头沟区医院呼吸与危重症医学科

出　　处：《中国社区医师》2019年第36期44-45,共2页Chinese Community Doctors

摘　　要：目的:探究无创双水平气道正压通气(BiPAP)治疗老年慢阻肺并发呼吸衰竭患者的临床效果及并发症影响。方法:2017年1月-2018年12月收治老年慢阻肺合并呼吸衰竭患者80例,随机分为两组,各40例。对照组采用常规治疗;试验组在常规治疗基础上采用无创双水平气道正压通气治疗。对比两组疗效。结果:试验组治疗后血气指标水平及临床治疗总有效率均优于对照组,差异有统计学意义(P<0.05);两组并发症发生率比较,差异无统计学意义(P>0.05)。结论:BiPAP治疗老年慢阻肺并发呼吸衰竭患者的临床效果确切,能显著改善患者血气指标水平,促进康复。Objective:To explore the effect and complications of noninvasive bi-level positive airway pressure(BiPAP)in the treatment of elderly patients with COPD complicated with respiratory failure.Methods:80 elderly patients with COPD and respiratory failure were selected from January 2017 to December 2018.They were randomly divided into the two groups with 40 cases in each group.The control group was treated with conventional therapy,and the experimental group was treated with noninvasive bi-level positive airway pressure on the basis of conventional treatment.We compared the effect of the two grops.Results:The level of blood gas index and the total effective rate of clinical treatment in the experimental group were better than those in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of complications between groups(P>0.05).Conclusion:Non-invasive bi-level positive airway pressure(BiPAP)is effective in the treatment of elderly patients with chronic obstructive pulmonary disease and respiratory failure.It can significantly improve the blood gas index and promote rehabilitation.

关 键 词：无创双水平气道正压通气 慢阻肺 呼吸衰竭 

分 类 号：R563.9[医药卫生—呼吸系统] R563.8[医药卫生—内科学]